Review explores intratumoral microbiota's roles in tumor progression, mechanisms, and therapies, suggesting future research avenues.
Tumor tissues, once considered sterile, actually host diverse microbial communities that play key roles in several physiological and pathological processes, closely related to tumorigenesis and progression. Studies have demonstrated that intratumoral microbiota potentially contributes to immune regulation and significantly influence cancer treatment outcomes. Here, we aim to provide an extensive review of the conceptual framework, potential origins, spatial heterogeneity, and analytical methodologies of intratumoral microbiota, explore their carcinogenic mechanisms and potential role in tumor prognosis. In addition, we discuss current therapeutic strategies that target intratumoral microbiota and highlight the research prospects and limitations in this field, although there are some inevitable challenges.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: